EUVIMEDEUVIMED entdecken
Open Access

HOXC9 characterizes a suppressive tumor immune microenvironment and integration with multiple immune biomarkers predicts response to PD-1 blockade plus chemotherapy in lung adenocarcinoma

Liang Liu, Zhenshan Zhang, Chenxue Jiang, Yaoyao Zhu, Ruiqin Han, Leilei Wu, Yaping Xu

Aging · 2024

DOI: 10.18632/aging.205637 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Aging, 2024. Verfasst von Liang Liu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Shanghai Pulmonary Hospital, School of Medicine, Tongji University, Shanghai 200433, China. Hauptthemen laut MEDLINE: Adenocarcinoma of Lung, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Adenocarcinoma of LungCarcinoma, Non-Small-Cell LungLung NeoplasmsAnimalsHumansMiceB7-H1 AntigenBiomarkers, TumorCarcinogenesisHomeodomain ProteinsProgrammed Cell Death 1 ReceptorTumor Microenvironment

Stichwörter der Autor:innen

HOXC9LUADTMEbiomarkerimmunotherapy

Substanzen

B7-H1 AntigenBiomarkers, TumorHomeodomain ProteinsHoxc9 protein, humanProgrammed Cell Death 1 ReceptorHoxc9 protein, mousePDCD1 protein, humanPdcd1 protein, mouse

Autor:innen und Institutionen

  • Department of Radiation Oncology, Shanghai Pulmonary Hospital, School of Medicine, Tongji University, Shanghai 200433, China.
  • Department of Radiation Oncology, Shanghai Proton and Heavy Ion Center, Fudan University Cancer Hospital, Shanghai 201315, China.
  • State Key Laboratory of Common Mechanism Research for Major Disease, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100191, China.

Zitieren

APA

Liu, L., Zhang, Z., Jiang, C., Zhu, Y., Han, R., Wu, L., & Xu, Y. (2024). HOXC9 characterizes a suppressive tumor immune microenvironment and integration with multiple immune biomarkers predicts response to PD-1 blockade plus chemotherapy in lung adenocarcinoma. Aging. https://doi.org/10.18632/aging.205637

Vancouver

Liu L, Zhang Z, Jiang C, Zhu Y, Han R, Wu L, et al. HOXC9 characterizes a suppressive tumor immune microenvironment and integration with multiple immune biomarkers predicts response to PD-1 blockade plus chemotherapy in lung adenocarcinoma. Aging. 2024. doi:10.18632/aging.205637

BibTeX
@article{Liu2024,
  author = {Liu, Liang and Zhang, Zhenshan and Jiang, Chenxue and Zhu, Yaoyao and Han, Ruiqin and Wu, Leilei and Xu, Yaping},
  title = {HOXC9 characterizes a suppressive tumor immune microenvironment and integration with multiple immune biomarkers predicts response to PD-1 blockade plus chemotherapy in lung adenocarcinoma},
  journal = {Aging},
  year = {2024},
  doi = {10.18632/aging.205637}
}
Kostenlos starten →